MMP-2 and Fibronectin were categorized as type I (developmental), and type II (fibrosis and wound healing) specific EMT markers, but not the type III EMT marker (cancer) (37), indicating that arsenic activates the fibrogenic-type EMT. This evidence concerns the gene MMP2 and cancer.